**Core Concept**
Bronchial asthma is a chronic inflammatory disorder of the airways characterized by recurring episodes of wheezing, shortness of breath, chest tightness, and coughing. The underlying pathophysiology involves airway inflammation, hyperresponsiveness, and reversible airflow obstruction.

**Why the Correct Answer is Right**
In bronchial asthma, the airway inflammation is mediated by the release of various cytokines and chemokines, leading to the activation of eosinophils and mast cells. This results in the production of bronchoconstrictor mediators such as leukotrienes, prostaglandins, and histamine, which cause bronchospasm and airway hyperresponsiveness. The airway remodeling process involves subepithelial fibrosis, smooth muscle hypertrophy, and goblet cell hyperplasia, contributing to the chronic nature of the disease.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because it does not accurately describe the pathophysiology of bronchial asthma.
**Option B:** This option is incorrect because it is not a characteristic of bronchial asthma.
**Option C:** This option is incorrect because it is not a key feature of bronchial asthma.

**Clinical Pearl / High-Yield Fact**
Asthma is a heterogeneous disease with multiple phenotypes, and the type 2 inflammatory pathway plays a central role in the pathogenesis of the disease. The use of biologic therapies targeting this pathway has revolutionized the treatment of severe asthma.

**Correct Answer: A.**